Company / PP&E (Net)
Viatris PP&E (Net) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.6B
FY2025
5-year range
$2.6B / $3.2B
FY2021-FY2025
Trend
-2.0%
vs FY2024
Sector context
#12 of 193
Health Care
What the data says
Among 193 Health Care companies, Viatris is in the top 6% for pp&e (net). PP&E (Net) has declined for 5 consecutive years, from $3.5B in FY2020 to $2.6B in FY2025.
Based on SEC 10-K filings.
$2.6B in FY2025 with a 5-year CAGR of -5.5%. Top quartile in the Health Care sector.
Declined from $2.8B to $2.6B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -4.7%
- 5-Year CAGR
- -5.5%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 193This company $2.6B Sector average $777.6M
▼
+236.1% above sector average
Key checks
Key Insights
- Viatris's pp&e (net) has declined for 5 consecutive years.
- 5-year CAGR of -5.5%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 2.0% year-over-year.
- Ranks #12 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.6B | -2.0% |
| FY2024 | $2.7B | -3.4% |
| FY2023 | $2.8B | -8.8% |
| FY2022 | $3.0B | -5.1% |
| FY2021 | $3.2B | -7.8% |
| FY2020 | $3.5B | +61.0% |
| FY2019 | $2.1B | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026